| abstract |
The present invention is directed to general formula (I): (I) [Wherein R1, R2, R3, R4, R5 and A are as defined in the claims] Substituted benzosulfonamide compounds of formula I, processes for the preparation of the compounds, pharmaceutical compositions and combinations containing the compounds and as a single substance or in combination with other active ingredients, diseases, in particular hyperproliferative diseases and It relates to the use of said compounds in the manufacture of a pharmaceutical composition for the treatment or prevention of angiogenic diseases. |